Implementation advice: health inequalities in type 2 diabetes
Limited evidence for some groups
Some groups are underrepresented in clinical trials and routine data. This includes people with early onset type 2 diabetes (diagnosed at age 40 or under), trans and non‑binary people and older, frailer people. It also includes asylum seekers, people experiencing homelessness and people from a Gypsy, Roma or Traveller community. Evidence gaps can make it harder to apply guideline recommendations confidently.
Why this matters
When evidence is limited, clinicians may be unsure about risks or benefits. This may lead to variations in care or hesitation in offering recommended therapies.
What you can do
Actions for providers and healthcare professionals
-
Use shared decision making and clinical judgment to personalise care by exploring preferences and priorities when evidence is limited, reviewing this regularly.
-
Support research participation and improve data collection by helping to remove barriers to research involvement and strengthen demographic recording.
Actions for commissioners
-
Support research participation and improve data collection by supporting research involvement and data collection.
This page was last updated: